George Coukos
George Coukos
University Hospital of Lausanne, Ludwig Institute for Cancer Research
Verified email at
Cited by
Cited by
A global reference for human genetic variation
1000 Genomes Project Consortium
Nature 526 (7571), 68, 2015
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ...
Nature medicine 10 (9), 942-949, 2004
Cancer immunotherapy comes of age
I Mellman, G Coukos, G Dranoff
Nature 480 (7378), 480-489, 2011
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang, JR Conejo-Garcia, D Katsaros, PA Gimotty, M Massobrio, ...
New England journal of medicine 348 (3), 203-213, 2003
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
F Martins, L Sofiya, GP Sykiotis, F Lamine, M Maillard, M Fraga, ...
Nature reviews Clinical oncology 16 (9), 563-580, 2019
Regulatory CD4+ CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
EY Woo, CS Chu, TJ Goletz, K Schlienger, H Yeh, G Coukos, SC Rubin, ...
Cancer research 61 (12), 4766-4772, 2001
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
microRNAs exhibit high frequency genomic alterations in human cancer
L Zhang, J Huang, N Yang, J Greshock, MS Megraw, A Giannakakis, ...
Proceedings of the National Academy of Sciences 103 (24), 9136-9141, 2006
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ...
Nature 475 (7355), 226-230, 2011
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Q Huang, K Gumireddy, M Schrier, C Le Sage, R Nagel, S Nair, DA Egan, ...
Nature cell biology 10 (2), 202-210, 2008
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
I Kryczek, M Banerjee, P Cheng, L Vatan, W Szeliga, S Wei, E Huang, ...
Blood, The Journal of the American Society of Hematology 114 (6), 1141-1149, 2009
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
GT Motz, SP Santoro, LP Wang, T Garrabrant, RR Lastra, IS Hagemann, ...
Nature medicine 20 (6), 607-615, 2014
T-regulatory cells: key players in tumor immune escape and angiogenesis
A Facciabene, GT Motz, G Coukos
Cancer research 72 (9), 2162-2171, 2012
Laser-capture microdissection
V Espina, JD Wulfkuhle, VS Calvert, A VanMeter, W Zhou, G Coukos, ...
Nature protocols 1 (2), 586-603, 2006
Modulation of the antitumor immune response by complement
MM Markiewski, RA DeAngelis, F Benencia, SK Ricklin-Lichtsteiner, ...
Nature immunology 9 (11), 1225-1235, 2008
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ...
Journal for immunotherapy of cancer 8 (1), 2020
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors
J Duraiswamy, KM Kaluza, GJ Freeman, G Coukos
Cancer research 73 (12), 3591-3603, 2013
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
L Zhang, S Volinia, T Bonome, GA Calin, J Greshock, N Yang, CG Liu, ...
Proceedings of the National Academy of Sciences 105 (19), 7004-7009, 2008
Deciphering and reversing tumor immune suppression
GT Motz, G Coukos
Immunity 39 (1), 61-73, 2013
The system can't perform the operation now. Try again later.
Articles 1–20